Sanquin Diagnostic Services

Foundation date

01/01/2017

Sector

#Biotechnology / R&D Services

Subsector

Sanquin Health Solutions represents the private/ commercial domain of Sanquin, responsible for all commercial activities serving the life sciences & health industry.

We are active in four core areas: Hematology, Immunology, Oncology and Transfusion Medicine with a strength in discovery/ early development.

The value SHS brings exceeds a standard CRO; with over 200 scientists we develop new technologies and assets for the LS&H industry, moreover, have access to the clinic, patient data and biomaterial (being able to better understand MoA and develop critical biomarkers).

We welcome LS&H companies to become a resident in our HID campus growing a strong ecosystem with over 120.000sqm in lab/office space and access to knowledge and platform technologies.

Upcoming events

Latest news

  • Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

    1 day ago

  • InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline

    Tuesday March 26th 2024

  • Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

    Monday March 25th 2024